Full-year EPS guidance raised to greater than $4.80 from $3.40
Centene delivered a strong Q2 2026 with EPS of $2.51, raising full-year guidance significantly to >$4.80. The company saw outperformance in Marketplace, Medicare PDP, and MA, with management focusing on margin restoration and AI-led efficiency. Medicaid attrition is running higher than expected, but rate improvements are offsetting the acuity impact. FY2026 EPS guidance raised to >$4.80 from >$3.40, driven by Marketplace margin recovery and strong PDP performance.
Buzzberg 분석Full-year EPS guidance raised to greater than $4.80 from $3.40Centene delivered a strong Q2 2026 with EPS of $2.51, raising full-year guidance significantly to >$4.80. The company saw outperformance in Marketplace, Medicare PDP, and MA, with management focusing on margin restoration and AI-led efficiency. Medicaid attrition is running higher than expected, but rate improvements are offsetting the acuity impact. FY2026 EPS guidance raised to >$4.80 from >$3.40, driven by Marketplace margin recovery and strong PDP performance.전체 분석 보기분석 접기
Centene delivered a strong Q2 2026 with EPS of $2.51, raising full-year guidance significantly to >$4.80. The company saw outperformance in Marketplace, Medicare PDP, and MA, with management focusing on margin restoration and AI-led efficiency. Medicaid attrition is running higher than expected, but rate improvements are offsetting the acuity impact. FY2026 EPS guidance raised to >$4.80 from >$3.40, driven by Marketplace margin recovery and strong PDP performance.
Marketplace pre-tax margin guidance raised to 4.5%-5% from 3%, supported by favorable risk adjustment and moderating trend.
Medicaid membership expected to decline 8-9% in 2026, with higher acuity in the expansion population offset by better-than-expected 7-1 rate increases.
Medicare PDP margin guidance raised to >3% for 2026, reflecting stable IRA impact and favorable drug trend.
Revenue$44.375B
-11% QoQ
EPS$2.51
-26% QoQ
Gross margin10.4%
reported
Op margin3.1%
reported
이번 분기에 달라진 점
01
Guidance
Full-year EPS guidance raised to greater than $4.80 from $3.40
Guidance tone
02
Marketplace
Marketplace margin expected at 4.5%-5% for 2026
FY2026 EPS guidance raised to >$4.80 from >$3.40, driven by Marketplace margin recovery and strong PDP performance.
03
Margins
PDP margin expectation raised to greater than 3%
Reported gross margin was 10.4%, reinforcing the quarter's better-than-guided profitability.
04
Medicaid
Medicaid enrollment decline expected at 8-9% for 2026
Medicaid membership expected to decline 8-9% in 2026, with higher acuity in the expansion population offset by better-than-expected 7-1 rate increases.
AI, 자본지출 및 수요 분석
AI
플랫폼 및 수익화
Centene is shifting AI strategy from individual use cases to foundational capabilities like trusted data products and dynamic context management, with a focus on ROI and scalability. Early AI use cases, such as invoice review in legal, are delivering savings, and the company sees long-term differentiation from proprietary data and context.
수요
수주 및 전환
Management raised FY2026 EPS guidance significantly and expressed confidence in margin restoration across business lines, pointing to strong execution and favorable market dynamics.
자본지출
투자 및 생산능력
No explicit capital expenditure or capacity investment details were provided, but the company is investing in AI and technology to drive efficiencies, with an expected $480 million midpoint of SG&A costs in 2026 related to workforce and enterprise optimization.
톤 · Confident
Management expressed strong confidence in improved financial guidance, robust execution across business segments, and strategic positioning for future margin restoration, despite acknowledged headwinds like Medicaid enrollment attrition and OB-3 implementation.
공급망 알파
A1
Medicaid membership attrition is accelerating, with full-year guidance now expecting a decline of 8-9% versus prior 6%, driven by state-level program changes and OB-3 preparation, leading to a slight uptick in acuity that management is absorbing.
“We expect full-year Medicaid membership to be down 8-9% compared to 12-31-25 versus our prior view of being down 6%.”
The 2025 marketplace risk adjustment reconciliation benefited the company by $180 million in Q2, and management now expects a 'meaningful receivable' in 2026, indicating a favorable position relative to the market risk pool.
“we received favorable development on our final 2025 CMS risk adjustment reconciliation to the tune of $180 million in the quarter.”